- Home
- QVCGA vs RADX Comparison
QVCGA vs RADX Comparison
Compare QVCGA & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- RADX
- Stock Information
- Founded
- QVCGA 1991
- RADX 2021
- Country
- QVCGA United States
- RADX Australia
- Employees
- QVCGA N/A
- RADX N/A
- Industry
- QVCGA
- RADX
- Sector
- QVCGA
- RADX
- Exchange
- QVCGA NYSE
- RADX NYSE
- Market Cap
- QVCGA 26.1M
- RADX 32.5M
- IPO Year
- QVCGA N/A
- RADX N/A
- Fundamental
- Price
- QVCGA $2.99
- RADX $4.20
- Analyst Decision
- QVCGA
- RADX Strong Buy
- Analyst Count
- QVCGA 0
- RADX 2
- Target Price
- QVCGA N/A
- RADX $13.50
- AVG Volume (30 Days)
- QVCGA 111.1K
- RADX 22.8K
- Earning Date
- QVCGA 08-07-2025
- RADX 02-26-2025
- Dividend Yield
- QVCGA N/A
- RADX N/A
- EPS Growth
- QVCGA N/A
- RADX N/A
- EPS
- QVCGA N/A
- RADX N/A
- Revenue
- QVCGA $9,800,000,000.00
- RADX $204,609.00
- Revenue This Year
- QVCGA $2.89
- RADX N/A
- Revenue Next Year
- QVCGA $0.45
- RADX N/A
- P/E Ratio
- QVCGA N/A
- RADX N/A
- Revenue Growth
- QVCGA N/A
- RADX N/A
- 52 Week Low
- QVCGA $2.27
- RADX $3.50
- 52 Week High
- QVCGA $39.74
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- RADX N/A
- Support Level
- QVCGA N/A
- RADX N/A
- Resistance Level
- QVCGA N/A
- RADX N/A
- Average True Range (ATR)
- QVCGA 0.00
- RADX 0.00
- MACD
- QVCGA 0.00
- RADX 0.00
- Stochastic Oscillator
- QVCGA 0.00
- RADX 0.00
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.